Dynavax Technologies reported $4.47M in Pre-Tax Profit for its second fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Pre Tax Profit Change
Adma Biologics ADMA:US $ -17.71M 0.39M
Alexion Pharmaceuticals ALXN:US $ 940.1M 164.6M
AstraZeneca AZN:LN 1954M 415M
Biogen BIIB:US $ 814.2M 255M
Bristol Myers Squibb BMY:US $ 5289M 67M
Chimerix CMRX:US $ -18.56M 0.8M
Idera Pharmaceuticals IDRA:US $ -5.96M 0.41M
Minerva Neurosciences NERV:US $ -9.2M 1.38M
Nektar Therapeutics NKTR:US $ -129.59M 4.43M
Neurocrine Biosciences NBIX:US $ 30.5M 27M
Novartis NOVN:VX SF 4544M 120M
Regeneron Pharmaceuticals REGN:US $ 1822.2M 2076.1M
Sarepta Therapeutics SRPT:US $ -47.91M 33.85M
Tg Therapeutics TGTX:US $ -85.64M 7.14M